United States · FDA National Drug Code directory
Imipenem and Cilastatin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-349_2bb9b6ad-8e8d-4667-b108-b57a8c16318f
- Product NDC
- 63323-349
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- Imipenem and Cilastatin Sodium
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120103
- Source listing expiry
- 20261231
Source-listed ingredients
- IMIPENEM — 250 mg/20mL
- CILASTATIN SODIUM — 250 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-349-25) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-349-01) · 63323-349-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →